resp important Flashcards

1
Q

COPD spirometry

A

FEV1/FVC ratio less than 70%, FEV1 less than 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

treatment COPD

A

1- SABA/SAMA
2- no asthmatic features: add LABA + LAMA (if taking SAMA, switch it to SABA)
3- asthmatic features: add LABA + ICS, if patients remain breathless then add LAMA also

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

first line antibiotics for infectious exacerbation of COPD

A

amoxicillin or clarithromycin or doxycycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Most frequent cause of COPD exacerbation

A

haemophilus influenzae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

COPD symptoms in a young person may be a sign of

A

A1AT deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how to tell severity of COPD

A

mild COPD- normal FEV1
moderate COPD- FEV1 50-70%
severe COPD- FEV1 30-49%
very severe FEV1<30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

clinical features Wegener’s granulomatosis

A
  • saddle nose/sinus pain/epistaxis
  • airway constriction- difficulty breathing, cough
  • kidney problems- reduced urine production, increased blood pressure, haematuria/proteinuria
  • skin purpura/nodules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

tests for Wegener’s granulomatosis

A
  • cANA- IgG antibody
  • increased ESR + CRP
  • CXR- fluffy infiltrates or nodules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

treatment Wegener’s granulomatosis

A
  • corticosteroids + cyclophosphamide (or rituximab) for disease remission
  • Azathioprine and methotrexate for maintenace
  • plasma exchange if severe renal disease & pulmonary haemorrhage
  • Co-trimoxazole - prophylaxis against pneumocystis jirovecii and staph colonisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

small cell cancer features

A

Paraneoplastic syndrome- ACTH, ADH and also can create autoantibodies that destroy neurones, causing lambert-eaton syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

adenocarcinoma features

A
  • can cause pancoast tumours in upper nerve
  • can damage thoracic inlet, brachial plexus and cervical sympathetic nerve; Horner’s syndrome (constricted pupil, drooping upper eyelid and cant sweat on same side as nerve damage)
  • Often see triad of clubbing, long bone swelling and arthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

squamous cell carcinoma features

A
  • Form square shaped cells that produce keratin pearls
  • Centrally located
  • Paraneoplastic syndrome possible- parathyroid hormone release, which decreases calcium in bones - leads to hypercalcaemia (more calcium in blood) and bones are more brittle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bronchial carcinoid tumour features

A
  • Develop from mature endocrine cells
  • Can be located throughout the lungs
  • Paraneoplastic syndrome- tumours release serotonin which causes increased peristalsis of gut, diarrhoea, and bronchoconstriction which causes asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

lung cancer associated with gynaecomastia

A

adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cancer with strongest associated with smoking

A

squamous cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

stats for moderate asthma

A

PEFR 50-75% best of predicted
RR<25/min
pulse <110

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

stats for severe asthma

A

PEFR 33-50% best of predicted
cannot complete sentences
RR >25/min
Pulse >110

18
Q

stats for life-threatening asthma

A
PEFR <33% best or predicted 
Oxygen sats <92% 
'normal' pCO2 
silent chest, cyanosis, feeble respiratory effect 
confusion or soma 
hypotension or bradycardia
19
Q

acute asthma attack management

A
1- oxygen 
2- salbutamol 
3- ipratropium bromide nebuliser 
4- IV hydrocortisone or oral Prednisolone 
5- magnesium sulfate IV
20
Q

investigations for asthma

A
  • FEV1/FVC <70% (obstructive)
  • peak flow- variability of more than 20% between am and pm measurements
  • fractional exhaled nitric oxide + bronchodilator reversibility test if the spirometry comes back normal despite symptoms
21
Q

asthma management in adults

A
1- SABA 
2- SABA + ICS 
3-  SABA + ICS + LABAS
4-ABA + ICS + LTRA (e.g. montelukast) 
5- SABA + LTRA + MART
22
Q

types of hypersensitivity

A

ACID
1- Allergy (immediate)- IgE
2- Cytotoxic- antibody dependent- IgM/IgG e.g. Goodpasture’s
3- Immune complex- IgG + neutrophils e.g. SLE, pneuomonitis, Wegener’s
4- Delayed hypersensitivity- cell mediated by T cells- e.g. Tuberculosis =, nickel, poison IV

23
Q

o Kidney biopsy: inflammation in the basement membrane- ‘crescent glomerulonephritis’
AND
CXR shows infiltrates due to pulmonary haemorrhage

A

Goodpasture’s syndrome (anti-glomerular basement membrane disease, a rare autoimmune disease in which antibodies attack the basement membrane in lungs and kidneys, leading to bleeding from the lungs and kidney failure.)

24
Q

diagnostic test for severity of Pneumonia + use of score

A
Confusion- 1 point 
Urea >7mmol/L - 1 point 
RR >30 - 1 point 
B: SBP<90 OR DBP <60- 1 
65- age over 65 

score of 0-1= home treatment, 2=admission/close outpatient management, 3-5= admission as severe

25
pneumonia antibiotics
 Strep pneumoniae / H. influenzae / mycoplasma pneumoniae = amoxicillin, clarithromycin or doxycycline  Legionella pneumophilia = fluroquinolone  Chlamoydophila species = tetracycline  Pneumocystis jiroveci = co-trimoxazole  Gram -ve bacilli / pseudomonas / anaerobes = aminoglycoside IV + antipseudomonal penicillin IV  Strep pneumoniae / anaerobes from aspiration = cephalosporin IV + metronidazole
26
most common organisms causing; 1- community acquired pneumonia 2- hospital acquired pneumonia
1- strep pneumoniae most common, but can also be caused by haemophilus influenzae or Moraxella 2- hospital acquired usually caused by staph aureus but may also be caused by pseudomonas, bacteriodes, clostridia
27
cell wall can hold onto dye despite being exposed to alcohol, which creates a bright red colour with a Ziehl-Neelson stain
mycobacterium tuberculosis
28
sarcoidosis signs/symptoms
- bilateral hilar lymphadenopathy - fever - erythema nodosum (swollen subcutaneous fat under ski, causing red bumps and patches) - polyarthralgia - uveitis- can cause vision changes
29
bilateral hilar lymphadenopathy
sarcoidosis
30
Facial rash plus lymphadenopathy
sarcoidosis
31
drugs which can cause pulmonary fibrosis
* Methotrexate * Nitrofurantoin * Amiodarone * Sulphasalazine * Bleoycin
32
features pleural effusion
dyspnoea, non-productive cough or chest pain are possible presenting symptoms classic examination findings include dullness to percussion, reduced breath sounds and reduced chest expansion
33
Pleural effusion: causes
Pleural effusions may be classified as being either a transudate or exudate according to the protein concentration. Transudate (< 30g/L protein) heart failure (most common transudate cause) hypoalbuminaemia (liver disease, nephrotic syndrome, malabsorption) hypothyroidism Meigs' syndrome ``` Exudate (> 30g/L protein) infection: pneumonia (most common exudate cause), TB, subphrenic abscess connective tissue disease: RA, SLE neoplasia: lung cancer, mesothelioma, metastases pancreatitis pulmonary embolism Dressler's syndrome yellow nail syndrome ```
34
pleural effusion investigations
- PA CXR - ultrasound- increases the likelihood of successful pleural aspiration and is sensitive for detecting pleural fluid septations; contrast CT is now also increasingly performed to investigate the underlying cause, particularly for exudative effusions - PLEURAL ASPIRATION
35
management pleural effusion
Options for managing patients with recurrent pleural effusions include: recurrent aspiration pleurodesis indwelling pleural catheter drug management to alleviate symptoms e.g. opioids to relieve dyspnoea
36
pneumothorax features
``` dyspnoea chest pain: often pleuritic sweating tachypnoea tachycardia ```
37
management pneumothorax
- first line aspiration | - if aspiration fails, insert chest drain
38
PE management
- large clots and haemodynamically unstable= alteplase 10mg over 1 min then 90mg over 2 hours - haemodynamically stable= LMWH then start oral anticoagulant
39
pink puffers and blue bloaters
differentiation in COPD: pink puffer= emphysema: high alveolar ventilation, near normal partial pressure of O2, normal or low partial pressure of CO2, breathless but not cyanosed, can progress to type 1 respiratory failure blue bloater= chronic bronchitis: have low alveolar ventilation, low partial pressure of O2, high partial pressure of CO2, cyanosed but not breathless, may develop cor pulmonale, their respiratory centres are insensitive to CO2 and they require a hypoxic drive to maintain respiratory effort (be careful when giving supplementary oxygen)
40
type I resp failure + causes
hypoxia (PaO2<8kPa) with normal or low pCO2 caused by ventilation /perfusion mismatch e.g. pneumonia, pulmonary oedema, PE, asthma, emphysema, pulmonary fibrosis, acute respiratory distress syndrome
41
type II resp failure + causes
hypoxia (PaO2<8kPa) with hypercapnia (PaCO2>6kPa) caused by: - pulmonary disease e.f. asthma, COPD, pneumonia, end stage pulmonary fibrosis, obstructive sleep apnoea - reduced respiratory drive- sedative drugs, CNS tumour, trauma - neuromuscular disease- cervical cord lesion, diaphragmatic paralysis, poliomyelitis, myasthenia gravis, guillan-barre syndrome - thoracic wall disease- flail test, hyphoscoliosis